| Cas No.: | 2162982-11-6 |
| Chemical Name: | AHR antagonist 1 |
| Synonyms: | BAY-218;AHR antagonist 1;(S)-6-(4-Chlorophenyl)-2-(3-fluorophenyl)-N-(1-hydroxypropan-2-yl)-3-oxo-2,3-dihydropyridazine-4-carboxamide;BCP31105;s8842;ZB1593;ClC1=CC=C(C=C1)C=1C=C(C(N(N=1)C1=CC(=CC=C1)F)=O)C(=O)N[C@H](CO)C |
| SMILES: | ClC1C=CC(=CC=1)C1C=C(C(N(C2C=CC=C(C=2)F)N=1)=O)C(N[C@@H](C)CO)=O |
| Formula: | C20H17ClFN3O3 |
| M.Wt: | 401.818687200546 |
| Purity: | >98%, chiral purity>98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | BAY2335218(BAY-218) showed IC50 values for human and murine AhR 45 and 43 nM, respectively, IC50 values of 76 and 66 for human and murine CYP1A1 mRNA in cellular functional assays, respectively. |
| References: | [1]. Norbert Schmees, et al. 3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides. WO2017202816A1. |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
